14th July 2026, Tuesday

TechPharus

Latest Posts

HealthTech News

  • Among young adults, alcohol-induced blackout are linked to more harmful consequences
    on July 14, 2026 at 7:00 pm

    Young adults who experienced alcohol-induced blackouts (AIBs) reported more alcohol-related consequences than they did when they drank similar amounts without blacking out, according to a new study. AIBs involve a period of amnesia while the person is conscious and interacting; they may not remember what happened. AIBs are linked to consequences ranging from embarrassment and hangovers to sexual risk and developing alcohol use disorder. Among college students with recent AIBs, one in three drinking days involves this type of blackout—perhaps in part because young adults often do not perceive AIBs negatively. For the study in Alcohol: Clinical & Experimental Research, investigators explored the role of social context (who people drink with) and location (where they drink) in the alcohol-related consequences of AIBs.

  • Mature eye cells turn back into stem cells after injury, mouse study finds
    on July 14, 2026 at 7:00 pm

    Researchers at Technion have uncovered a surprising natural mechanism through which the body repairs itself: Contrary to what was previously believed, mature, aged cells retain an extraordinary ability to “turn back time” and revert to active stem cells that regenerate damaged tissue.

  • Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer
    on July 14, 2026 at 6:40 pm

    Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stages of the disease still requires more precise tools. Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have now tested a novel approach. A combination of two diagnostic imaging techniques could pave the way for personalized radiotherapy. The results of the study have been published in the Journal of Medicinal Chemistry.

  • Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines
    on July 14, 2026 at 6:40 pm

    A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical findings that warrant further investigation. The results also point to potential biomarkers that may help identify patients most likely to benefit from this approach.

  • Seatbelts still essential, but nearly 9 in 10 pregnant people didn’t achieve recommended seatbelt placement
    on July 14, 2026 at 6:26 pm

    Nearly nine in 10 pregnant participants in a study led by biomedical engineers at UBC did not achieve recommended seat belt placement, even after instruction and hands-on guidance. Among 333 participants, only 11.4% were able to place the seat belt as recommended, suggesting current seat belt guidance may be difficult for many pregnant people to achieve in practice.